Pacira to Pay Termination Fee of About $7.3 Million to CrossLink

July 1, 2016 |

1 min read

* In connection with termination of agreement, fee based on percentage of earned performance-based fees will be due to CrossLink

* Termination fee in connection with agreement with CrossLink Bioscience related to promotion and sale of exparel

Alliances

MORE ON THIS TOPIC

cutting off a row of people into pieces

Layoffs

Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner

December 13, 2024

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff

December 12, 2024

·

205 min read

·

BioSpace Editorial Staff

Podcast

Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More

December 11, 2024

·

1 min read

·

Heather McKenzie

Group Of Employees Being Fired By Their Company.

Layoffs

Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline

December 10, 2024

·

2 min read

·